中国结合医学杂志（英文版）Chinese Journal of Integrative Medicine

Author Name	Affiliation	E-mail
Zhang Qiong	The National Clinical Base of Drug Research, Xiyuan Hospital, China Academy of Traditional Chinese Medicine, 100091, Beijing	zhangq810@263.net
Peng Jian-hua	Deyuantang Pharmaceutical Ltd. Co., Shangxi
Zhang Xiang-nong	People’s Hospital of Qingdao, China

Hits: 1200

Download times: 519

Abstract:

Objective: To evaluate the clinical effect and safety of Safflower Yellow injection (SYI) in treating coronary heart disease angina pectoris (CHD-AP) with Xin-blood stagnation syndrome (XBSS).Methods: Adopted was the multi-centered, randomized, positive parallel controlled method, 448 patients with CHD-AP-XBSS were enrolled and divided into two groups, 336 in the tested group treated with SYI and112 in the control group treated with Salvia injection by intravenous dripping once a day for 14 days, so as to observe the conditions of angina, electrocardiogram, and therapeutic effect on traditinal Chinese medicine(TCM) symptoms as well as the safety of the treatment. Results: The significantly effective rate and total effective rate in the tested group were 60.06% (194/323) and 91.02% (294/323) respectively; those in improvement of TCM symptoms were 40.18% (129/321) and 75.23% (243/323) respectively, which were better than those in the control group (P＜0.01). Conclusion: SYI Injection is effective and safe in treating CHD-AP-XBSS.